Workflow
生物制造
icon
Search documents
十五五,攻坚牛——2026年度策略
2025-12-17 15:50
2025 年金融市场改革通过基准指引强化市场约束,推动基金从规模导 向转变为利益导向,ETF 追涨现象明显,IPO 节奏偏紧,减持处于低位, 明年关注高景气出口链、周期股和消费反转领域。 十五五,攻坚牛——2026 年度策略 20251217 摘要 中国经济在"十五"期间有望突破美国 GDP 的 70%,工业增加值已达 美国的 1.6 倍,得益于研发投入和工业体系建设,打破"日本化"叙事, 展示高质量发展基础。 美国面临债务加剧和财政赤字挑战,长期经济潜在增长率或仅为 1.2%,政府债务率上升引发对美债安全性的担忧,促使海外投资者减少 美债配置,央行增持黄金。 未来五年,中国投资机会集中在产业升级、科技创新和消费提升领域, 高比例研发投入和完整工业体系为应对外部技术封锁提供坚实基础。 中国将通过优化提升传统产业,培育量子科技、生物制造、氢能与核聚 变、脑机接口等新兴产业,并强化基础设施建设,以适应新的发展阶段 需求。 中国出口份额不断创新高,对美依赖度已降至 10%以下,通过多元化策 略保障出口韧性,贸易顺差持续扩大,竞争力显著增强。 为应对消费疲软,中国将提高居民消费率作为主要目标,优化"两新" 政策,加强 ...
为企业上市画龙点睛!宁乡市携手北交所、湖南股交所,助力优质公司进军资本市场
Sou Hu Cai Jing· 2025-12-17 12:47
长沙晚报掌上长沙12月17日讯(全媒体记者 张禹)岁末育生机,蓄力正当时。12月17日,宁乡市民之 家三楼会议室暖意融融、智慧涌动,一场专为企业上市量身定制的培训活动在此举行。北京证券交易所 (下称"北交所")、湖南股权交易所(下称"湖南股交所")的专家团队如约而至,为近40家上市后备企 业传经送宝,与宁乡市、宁乡经开区的领导干部共话资本市场新机遇,为当地企业登陆资本市场注入强 劲信心与专业动能。 捷报振信心,产业沃土育壮苗 政企共携手,奔赴上市"新蓝海" 企业勇闯资本市场,政府当好"护航员"。宁乡早已用行动践行承诺:每月的"书记直通车""市长企业接 待日"累计解决难题660余个,还专门开设"拟上市企业专场"精准破题。从"科创桥计划"打通成果转化瓶 颈,到35亿元产业基金矩阵提供资本支持,宁乡正以"股东式服务"为企业发展和上市扫清障碍。 这份底气,源于宁乡厚积薄发的产业根基。据介绍,整合后的宁乡经开区已形成"三主一特一新"产业格 局,拥有2000余家工业企业,其中国家级专精特新"小巨人"企业30家,本土上市企业4家。加加食品作 为"全国酱油第一股"深耕食品赛道,楚天科技在合成生物制造领域领跑,松井股份以科创实 ...
谭天伟院士揭秘生物制造:30万亿美元未来产业的三大挑战和趋势
Core Viewpoint - The article emphasizes that China is poised to play a significant role in the future of biomanufacturing, which is expected to create an economic value exceeding $30 trillion by 2050, marking it as a core driver of the next industrial revolution [2][7]. Summary by Sections What is Biomanufacturing? - Biomanufacturing transforms living organisms, such as microorganisms and cells, into "smart factories" that produce various substances needed by humans. This process marks a fundamental shift from traditional manufacturing, which relies on fossil resources, to using renewable resources like sugar, straw, and carbon dioxide [2][3]. Importance of Biomanufacturing - Biomanufacturing is crucial for achieving carbon neutrality as it significantly reduces carbon emissions by utilizing renewable resources instead of fossil fuels. It allows for a broader range of raw materials and a greener manufacturing process, making factories resemble ecosystems [3]. - The potential for programmable manufacturing is immense, as scientists can design microorganisms to produce specific molecules, akin to writing code, thus unlocking vast possibilities [3]. Impact on Daily Life - In the food sector, cell-cultured meat and new food ingredients like microbial proteins are becoming mainstream. - The fashion industry is seeing innovations such as bio-silk from bacteria and biodegradable textiles from algae and fungi. - In construction, "bio-bricks" made from fungal mycelium can self-repair and absorb carbon dioxide, potentially transforming buildings into "green life forms." - Transportation is advancing with the production of aviation fuel from carbon dioxide, and biomanufacturing is also contributing to greener lubricants and tire rubbers. - In healthcare, biomanufacturing can streamline drug synthesis, enabling personalized medicine and potentially allowing hospitals to "print" drugs and organs [4]. Challenges and Future Trends - Biomanufacturing faces challenges such as the need for improved foundational capabilities in gene editing and enzyme engineering, difficulties in scaling from lab to industrial production, and the lack of a comprehensive policy and standards framework [5]. - Future trends include the integration of artificial intelligence in biomanufacturing, enabling rapid strain improvement, carbon cycling in manufacturing processes, and cross-industry collaborations that will create new industrial ecosystems [6]. Opportunities for China - China has advantages in fermentation capacity, industrial scale, and engineering experience. The government is actively promoting biomanufacturing as a new growth engine, positioning the country to take a leading role in this transformative industry [7].
国投集团锚定新质蛋白赛道,构建央企生物制造产研融合发展新模式
Di Yi Cai Jing· 2025-12-16 03:49
国务院国资委2023年启动实施央企产业焕新行动和未来产业启航行动,聚焦新一代移动通信、人工智能、生物制造、新材料等15个重点产业领域方向,推动 中央企业加快布局和发展新兴产业。 国投集团称,此次合作标志着国投集团在新质蛋白领域构建起"技术研发+产业落地"的完整链路,是发挥央企科技引领与产业带动作用的关键一步,为生物 制造这一国家战略产业注入强劲动力。 新质蛋白产业基于合成生物学技术,通过工业微生物发酵方式对农耕、畜牧等传统蛋白质获取方式进行改革升级,是生物制造新质生产力的典型代表。 国投集团投资布局生物制造领域项目118个、金额225亿元,带动投资超千亿元。 中国工程院院士陈坚表示,生物制造正处在从科技向产业转化的爆发期,产业规模将从2025年的1.6万亿发展到2030年的3万亿元。 中国科学院天津工业生物技术研究所研究员李德茂谈到,新质蛋白是近年来在保障粮食安全和可持续发展背景下兴起的一个重要概念,旨在减少对传统养殖 业的依赖,是全球生物安全的战略必争之地。随着我国技术的快速发展,国际上对我国构成的专利和产品的垄断正在改观。 "十五五"规划建议明确提出要前瞻布局未来产业,推动生物制造等成为新的经济增长点。 ...
冷暖之间,淬炼底气与韧性 | 年度对话×财经年会2026前瞻
Sou Hu Cai Jing· 2025-12-15 13:42
文|齐元 2025年,北方的冬天比往年来得要早一些,京西门头沟的初雪下在十月中旬,早早入了冬;直到两个月 后,城区才正式飘了雪。上海的金秋刚刚被一场小雨送走,千里之外的大湾区,全运会的运动员们仍在 赛场上身着短袖,挥汗如雨。 大江南北的人们,体感温度是如此不同。经济,亦如这天气。 有人在行业调整与成本压力中直面严寒,有人在政策红利与技术革新中感受热浪;一面是卷到冒烟的职 场,一面是方兴未艾的赛场;红海与蓝海伴游,展期与展望同在。经济的冷暖抽象又具体,宏大又微 茫,迭代疾快却周期漫长,丝丝缕缕渗透到每个行业的肌理,兜兜转转最终落到每个人的肩上。 从白山黑水到南海之滨,从东部沿海到西部内陆,区域的"温差"同样呈现出丰富层次——有的区域正在 转型调整中感受经济周期转换的凉意,有的区域则在创新驱动下展现持续升温的活力——多元景象的背 后,是中国经济高质量发展的不同维度。 那些感到"寒意"的地方,其感知源于内外双重压力的叠加。宏观层面,内需的信心尚待提振,外部关税 博弈又频频袭来,共同构成了当前经济周期的核心挑战。映射到具体地域,则是传统产业区与资源型城 市正经历的"刮骨疗毒"。它们要摆脱"靠山吃山"的路径依赖,转向创 ...
未来产业周报第1期:量子万比特芯片技术突破,核聚变国际协作升级-20251214
Quantum Technology - The report highlights the release of the world's first 3D-extended architecture 10,000-qubit quantum processor VIO-40K by QuantWare, which aims to overcome the scaling bottleneck of quantum processors and is compatible with NVIDIA's NVQLink platform [3][7][8] - The 2025 Zhongguancun Quantum Conference announced 16 quantum technology achievements and a 500 million yuan investment fund to support quantum entrepreneurship, showcasing advancements in quantum computing and applications in energy [3][13][14] Biomanufacturing - Levinthal Biotech completed a multi-million Pre-A round financing to accelerate the development of its AI-driven full-atom model protein design platform Pallatom, which addresses the design challenges of cyclic peptides [3][15][16] - Aopu Mai's acquisition of 100% of Pengli Biotechnology was approved, enhancing its capabilities in cell culture media and CDMO services, thereby expanding its market position [3][20][21] - Baiaosaitu has established a dual-platform listing strategy with its recent listing on the STAR Market, focusing on innovative drug development driven by gene editing technology [3][23][24] Hydrogen Energy and Nuclear Fusion - The report notes the deepening international cooperation in nuclear fusion, with a Chinese expert set to chair the ITPA Coordination Committee from 2026 to 2028, and the signing of a contract for the mass production of the ITER first wall [3][28][29] - Snowman Group's metal plate fuel cell stack project has passed final acceptance, marking a significant step in the commercialization of hydrogen energy technology [3][30][31] Brain-Computer Interface - Neuralink has demonstrated a significant efficiency breakthrough with its new surgical robot, reducing the electrode implantation time from 17 seconds to 1.5 seconds, showcasing advancements in surgical precision and safety [3][34][46] - The report emphasizes the competitive landscape, with the U.S. leading in invasive technologies while China excels in non-invasive applications, highlighting the ongoing developments in both sectors [3][48][49] Embodied Intelligence - Beijing Humanoid Robotics has launched the first fully autonomous humanoid robot tour guide solution, integrating IoT capabilities for various applications in exhibition halls and shopping malls [3][50][51] - The Shanghai humanoid robot pilot alliance was established to enhance the supply chain for humanoid robots, indicating a collaborative effort to scale the industry [3][53][54] - Yushu Technology has introduced a humanoid robot App Store, allowing users to upload and share action models, further promoting the commercialization of humanoid robotics [3][55]
中央经济工作会议后,市场如何表现?
Soochow Securities· 2025-12-13 11:08
Core Insights - The report indicates that the 2025 Central Economic Work Conference is more focused on "structural adjustment," suggesting a potential for a structural market trend in the upcoming year [4][6][26] - Historical patterns show that years emphasizing "stabilizing growth" typically lead to stronger market performance, favoring large-cap stocks over small-cap and value stocks over growth stocks [2][10] - Conversely, years focused on "structural adjustment" tend to exhibit market volatility, with large-cap stocks remaining flat while small-cap stocks weaken [2][10] Summary by Sections Historical Performance Post-Central Economic Work Conference - The report categorizes past conferences into two themes: "stabilizing growth" and "structural adjustment," with specific years identified for each theme [1][2] - Years with a "stabilizing growth" focus include 2014, 2018, 2019, 2021, 2022, and 2024, characterized by economic slowdowns and policies aimed at maintaining stability [1][2] - Years emphasizing "structural adjustment" include 2013, 2015, 2016, 2017, 2020, and 2023, where the focus was on addressing structural issues and risks [2] Market Behavior and Style Preferences - In "stabilizing growth" years, the market index typically strengthens, with large-cap stocks outperforming small-cap stocks and value stocks outperforming growth stocks [2][10] - In "structural adjustment" years, the market tends to be more volatile, with large-cap stocks showing flat performance and small-cap stocks declining [2][10] Industry Performance Insights - The report notes that the focus of the Central Economic Work Conference influences the following year's market trends, with specific industry policies guiding investment directions [3][4] - For instance, the emphasis on "innovation-driven" policies in 2012 led to a TMT boom in 2013, while the focus on "new consumption" and "new infrastructure" in 2018 shaped market trends in 2019 [3] 2025 Conference Insights - The 2025 conference highlights a "supply strong, demand weak" scenario, indicating a need to balance supply and demand dynamics [4][6] - The report suggests that monetary policy will prioritize economic stability and reasonable price recovery, which could lead to improved corporate profitability if inflation expectations rise [6] - Expanding domestic demand is a key focus, with policies aimed at increasing consumer income and stabilizing investment to counteract previous declines in fixed asset investment growth [6] Market Outlook and Sector Allocation - The report anticipates a structural market trend in 2025, with specific sectors recommended for investment, including AI applications, semiconductor, and renewable energy sectors [7] - The report emphasizes the importance of monitoring macroeconomic conditions and policy developments to inform investment strategies in the upcoming year [7]
生物制造:以生命为动力的未来工厂(院士讲科普)
Ren Min Ri Bao· 2025-12-12 22:00
Core Viewpoint - Biomanufacturing is emerging as a transformative industry that utilizes living organisms to produce essential materials, marking a shift from traditional manufacturing methods reliant on fossil fuels to more sustainable practices using renewable resources [5][6]. Group 1: Definition and Importance of Biomanufacturing - Biomanufacturing involves using microorganisms, animal, or plant cells to produce desired substances by designing and controlling their metabolic pathways [5]. - This industry combines traditional fermentation techniques with synthetic biology, allowing for the production of pharmaceuticals, flavors, plastics, and fuels from renewable resources like sugar and carbon dioxide [5][6]. - It is considered a future industry because it represents a new manufacturing path driven by life, rather than an extension of traditional industries [5]. Group 2: Environmental and Economic Impact - Biomanufacturing is crucial for achieving carbon neutrality goals, as it utilizes renewable resources instead of fossil fuels, enabling a "carbon cycle" approach [6]. - Predictions suggest that by 2050, approximately 60% of industrial products could be produced through biomanufacturing, potentially generating an economic value exceeding $30 trillion [6]. Group 3: Current Developments in China - China is accelerating its biomanufacturing industry, with government reports emphasizing the need to cultivate new growth engines, including biomanufacturing [7]. - The country has established leading advantages in fermentation capacity, industrial scale, and engineering experience, positioning itself favorably in the future development of this industry [7]. Group 4: Innovations and Applications - Biomanufacturing is reshaping traditional production logic, enabling the cultivation of lab-grown meat and the production of microbial proteins and synthetic dairy products without livestock [8]. - In the fashion industry, biomanufacturing offers sustainable alternatives, such as bio-silk and mycelium leather, which can replace petroleum-based textiles [8]. - In construction, "bio-bricks" made from fungal mycelium and mineral particles can self-repair and absorb carbon dioxide, contributing to eco-friendly building practices [8]. Group 5: Challenges and Future Trends - Key challenges include the need for foundational capabilities in gene editing, strain design algorithms, and metabolic pathway databases, which are currently weak in China [10]. - The transition from laboratory success to industrial application faces hurdles, including process complexity and cost control [11]. - Future trends indicate a convergence of artificial intelligence with biomanufacturing, enhancing the design of living organisms, and a shift towards carbon circular manufacturing, where factories can utilize carbon dioxide as a raw material [12].
70个民企产业项目在福州集中签约 总投资逾千亿元
Zhong Guo Xin Wen Wang· 2025-12-12 12:11
Core Insights - The event in Fuzhou led to the signing of 70 major industrial projects with a total investment of 112.39 billion RMB, aimed at enhancing high-quality connections between private enterprises and promoting deep integration of industries between Fujian and Taiwan [1][2] Group 1: Project Overview - The signed projects include 57 emerging industry projects in sectors such as new energy, new materials, integrated circuits, and biomanufacturing [1] - Notable projects include a 12-inch high-end analog integrated circuit chip manufacturing facility in Xiamen and a 5.57 million ton annual integrated expansion project in Zhangpu, both valued at over 10 billion RMB [1] - The projects are expected to generate an additional annual output value of over 130 billion RMB for Fujian Province once operational [2] Group 2: Participation and Scope - The event attracted over 500 representatives from various regions, including nearly 70 Taiwanese enterprises, highlighting the strong interest in biopharmaceutical cooperation [1] - The projects cover a wide range of fields, including advanced sectors like AI, robotics, and low-altitude economy, as well as traditional industries such as green chemicals and modern textiles [2] - Since the beginning of the year, Fujian Province has facilitated the connection of 2,220 private enterprise projects with a planned total investment of 400.9 billion RMB, achieving an 83.3% commencement rate for manufacturing projects [2]
湖南“十五五”规划建议:推进国家中药材种质研究重大科技基础设施、飞行器起降安全实验设施等建设
人民财讯12月12日电,中共湖南省委关于制定湖南省国民经济和社会发展第十五个五年规划的建议发 布。其中提出,加强原始创新和关键核心技术攻关。加大全社会研发经费投入,鼓励企业加大基础研究 投入。推动集成电路、先进材料、未来能源、生物制造等重点领域关键核心技术攻关取得突破,破解一 批"卡脖子"难题。推进国家中药材种质研究重大科技基础设施、飞行器起降安全实验设施等建设。建设 任务导向型实验室体系,争创更多全国重点实验室。深化长株潭国家自主创新示范区建设。培育建设一 批国家技术创新中心、产业技术工程化中心、制造业创新中心等国家级创新平台。健全创新平台基地统 筹管理机制,构建高效开放协同的创新平台体系。 ...